Common Stock, Shares Authorized of AGILE THERAPEUTICS INC from Q2 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Agile Therapeutics Inc quarterly Common Stock, Shares Authorized history and change rate from Q2 2014 to Q2 2024.
  • Agile Therapeutics Inc Common Stock, Shares Authorized for the quarter ending 30 Jun 2024 was 300M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

AGILE THERAPEUTICS INC Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 300M 0 0% 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 300M 0 0% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 300M 0 0% 31 Dec 2023 10-Q 12 Aug 2024
Q3 2023 300M 0 0% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 300M 0 0% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 300M 0 0% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 300M 0 0% 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 300M +150M +100% 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 300M +150M +100% 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 300M +150M +100% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 300M +150M +100% 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 150M 0 0% 30 Sep 2021 10-Q/A 30 Dec 2021
Q2 2021 150M 0 0% 30 Jun 2021 10-Q 26 Jul 2021
Q1 2021 150M 0 0% 31 Mar 2021 10-Q 04 May 2021
Q4 2020 150M 0 0% 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 150M 0 0% 30 Sep 2020 10-Q 12 Nov 2020
Q2 2020 150M 0 0% 30 Jun 2020 10-Q 11 Aug 2020
Q1 2020 150M 0 0% 31 Mar 2020 10-Q 05 May 2020
Q4 2019 150M 0 0% 31 Dec 2019 10-K 01 Mar 2021
Q3 2019 150M 0 0% 30 Sep 2019 10-Q 28 Oct 2019
Q2 2019 150M 0 0% 30 Jun 2019 10-Q 01 Aug 2019
Q1 2019 150M 0 0% 31 Mar 2019 10-Q 03 May 2019
Q4 2018 150M 0 0% 31 Dec 2018 10-K 20 Feb 2020
Q3 2018 150M 0 0% 30 Sep 2018 10-Q 02 Nov 2018
Q2 2018 150M 0 0% 30 Jun 2018 10-Q 03 Aug 2018
Q1 2018 150M 0 0% 31 Mar 2018 10-Q 07 May 2018
Q4 2017 150M 0 0% 31 Dec 2017 10-K 12 Mar 2019
Q3 2017 150M 0 0% 30 Sep 2017 10-Q 06 Nov 2017
Q2 2017 150M 0 0% 30 Jun 2017 10-Q 28 Jul 2017
Q1 2017 150M 0 0% 31 Mar 2017 10-Q 08 May 2017
Q4 2016 150M 0 0% 31 Dec 2016 10-K 12 Mar 2018
Q3 2016 150M 0 0% 30 Sep 2016 10-Q 07 Nov 2016
Q2 2016 150M 0 0% 30 Jun 2016 10-Q 08 Aug 2016
Q1 2016 150M 0 0% 31 Mar 2016 10-Q 09 May 2016
Q4 2015 150M 0 0% 31 Dec 2015 10-K 15 Mar 2017
Q3 2015 150M 0 0% 30 Sep 2015 10-Q 09 Nov 2015
Q2 2015 150M 0 0% 30 Jun 2015 10-Q 13 Aug 2015
Q1 2015 150M 31 Mar 2015 10-Q 12 May 2015
Q4 2014 150M 31 Dec 2014 10-K 09 Mar 2016
Q3 2014 150M 30 Sep 2014 10-Q 13 Nov 2014
Q2 2014 150M 30 Jun 2014 10-Q 14 Aug 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.